Texas
LATEST FROM BIOSPACE
Preclinical data for its drug candidate, LP-184, reportedly showed over 90 percent efficacy in shrinking pancreatic cancer tumors in mouse models in vitro, in-vivo, and ex-vivo.
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
Every week there are numerous scientific studies published. This week there was an unusual number of research stories revolving around Alzheimer’s disease. Here’s a look at some of the more interesting ones.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
As BioSpace releases its third annual 2021 U.S. Life Sciences Salary Report, there are hopeful surprises and unsettling truths.
Please check out the biopharma industry’s COVID-19 stories that are trending for June 22, 2021.
The data showed that both experimental therapies restored function in the cystic fibrosis transmembrane conductance regulator gene.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Please check out the biopharma industry’s COVID-19 stories that are trending for June 8, 2021.
The three companies will aim to develop their different programs such as Stablix TPS platform, Stellanova’s focused on targeting pro-tumorigenic effects, and Amyl’s development of preclinical therapeutic candidates.
PRESS RELEASES